Parimal Misra

2.5k total citations
63 papers, 2.0k citations indexed

About

Parimal Misra is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Parimal Misra has authored 63 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 23 papers in Organic Chemistry and 12 papers in Surgery. Recurrent topics in Parimal Misra's work include Metabolism, Diabetes, and Cancer (18 papers), Peroxisome Proliferator-Activated Receptors (16 papers) and Synthesis and biological activity (14 papers). Parimal Misra is often cited by papers focused on Metabolism, Diabetes, and Cancer (18 papers), Peroxisome Proliferator-Activated Receptors (16 papers) and Synthesis and biological activity (14 papers). Parimal Misra collaborates with scholars based in India, United States and Australia. Parimal Misra's co-authors include Ranjan Chakrabarti, Janardan K. Reddy, Manojit Pal, Braj B. Lohray, Reeba K. Vikramadithyan, Chao Qi, Mahendra S. Rao, Ramanujam Rajagopalan, D. Rambabu and Kamlesh Bhatt and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Chemical Communications.

In The Last Decade

Parimal Misra

62 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Parimal Misra India 27 1.1k 679 247 232 194 63 2.0k
Jeffrey A. Robl United States 23 1.0k 0.9× 668 1.0× 185 0.7× 242 1.0× 199 1.0× 61 1.9k
Mitchell A. Avery United States 21 842 0.8× 462 0.7× 266 1.1× 224 1.0× 383 2.0× 41 2.3k
Antonella Del Corso Italy 28 1.1k 1.0× 377 0.6× 256 1.0× 148 0.6× 225 1.2× 103 2.2k
Toshimasa Itoh Japan 22 791 0.7× 250 0.4× 200 0.8× 86 0.4× 178 0.9× 68 1.5k
Cecilia S. Koble United States 11 1.6k 1.5× 239 0.4× 644 2.6× 305 1.3× 251 1.3× 16 2.3k
András Váradi Hungary 20 738 0.7× 457 0.7× 127 0.5× 87 0.4× 194 1.0× 60 1.9k
Dennis Dean United States 25 614 0.6× 571 0.8× 88 0.4× 100 0.4× 171 0.9× 66 2.0k
Richard Sulsky United States 12 640 0.6× 203 0.3× 165 0.7× 239 1.0× 135 0.7× 18 1.1k
Mark M. Yore United States 19 2.2k 2.1× 184 0.3× 531 2.1× 422 1.8× 138 0.7× 21 3.1k
Junya Ito Japan 23 667 0.6× 296 0.4× 163 0.7× 100 0.4× 59 0.3× 74 1.6k

Countries citing papers authored by Parimal Misra

Since Specialization
Citations

This map shows the geographic impact of Parimal Misra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parimal Misra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parimal Misra more than expected).

Fields of papers citing papers by Parimal Misra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parimal Misra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parimal Misra. The network helps show where Parimal Misra may publish in the future.

Co-authorship network of co-authors of Parimal Misra

This figure shows the co-authorship network connecting the top 25 collaborators of Parimal Misra. A scholar is included among the top collaborators of Parimal Misra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parimal Misra. Parimal Misra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, K. Shiva, Anwar Alam, Sandipan Chakraborty, et al.. (2025). Early preclinical development of Mycobacterium tuberculosis amino acid biosynthesis pathway inhibitor DRILS-1398 as a potential anti-TB drug. iScience. 28(6). 112537–112537.
2.
Chakraborty, Sandipan, et al.. (2024). An inexpensive, metal-free and one-pot approach towards N-sulfonyl amidines: Identification of a chorismate mutase inhibitor with activities against S. aureus. Journal of Molecular Structure. 1312. 138531–138531. 1 indexed citations
3.
Misra, Parimal, et al.. (2024). A microneedle transdermal patch loaded with iron(ii) nanoparticles for non-invasive sustained delivery to combat anemia. Materials Advances. 5(8). 3247–3256. 1 indexed citations
4.
Chakrabarti, Partha, Om Tantia, Manjunath B. Joshi, et al.. (2023). TGS1/PIMT knockdown reduces lipid accumulation in adipocytes, limits body weight gain and promotes insulin sensitivity in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(1). 166896–166896. 1 indexed citations
5.
Chakrabarti, Partha, et al.. (2023). PIMT Controls Insulin Synthesis and Secretion through PDX1. International Journal of Molecular Sciences. 24(9). 8084–8084. 3 indexed citations
6.
7.
Kapadia, Bandish, et al.. (2023). PIMT regulates hepatic gluconeogenesis in mice. iScience. 26(3). 106120–106120. 5 indexed citations
8.
Kapadia, Bandish, Vasundhara Kain, Phanithi Prakash Babu, et al.. (2018). ERK1/2 activated PHLPP1 induces skeletal muscle ER stress through the inhibition of a novel substrate AMPK. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(5). 1702–1716. 22 indexed citations
9.
Alvala, Mallika, K. Shiva Kumar, Raj Patel, et al.. (2017). Mycobacterium tuberculosis chorismate mutase: A potential target for TB. Bioorganic & Medicinal Chemistry. 25(6). 1725–1736. 41 indexed citations
10.
Kain, Vasundhara, Bandish Kapadia, Navin Viswakarma, et al.. (2015). Co-activator binding protein PIMT mediates TNF-α induced insulin resistance in skeletal muscle via the transcriptional down-regulation of MEF2A and GLUT4. Scientific Reports. 5(1). 15197–15197. 24 indexed citations
11.
Adepu, Raju, K. Shiva Kumar, D. Rambabu, et al.. (2012). C–N bond formation under Cu-catalysis: Synthesis and in vitro evaluation of N-aryl substituted thieno[2,3-d]pyrimidin-4(3H)-ones against chorismate mutase. Bioorganic & Medicinal Chemistry. 20(17). 5127–5138. 11 indexed citations
12.
Kumar, K. Shiva, Raju Adepu, D. Rambabu, et al.. (2011). Cu-mediated N-arylation of 1,2,3-triazin-4-ones: Synthesis of fused triazinone derivatives as potential inhibitors of chorismate mutase. Bioorganic & Medicinal Chemistry Letters. 22(2). 1146–1150. 42 indexed citations
13.
Reddy, G. Rajeshwar, et al.. (2011). A Pd-mediated new strategy to functionalized 2-aminochromenes: Their in vitro evaluation as potential anti tuberculosis agents. Bioorganic & Medicinal Chemistry Letters. 21(21). 6433–6439. 27 indexed citations
14.
Chakrabarti, Ranjan, et al.. (2004). Antidiabetic and hypolipidemic potential of DRF 2519—a dual activator of PPAR-α and PPAR-γ. European Journal of Pharmacology. 491(2-3). 195–206. 42 indexed citations
15.
Pal, Manojit, et al.. (2003). Synthesis and cyclooxygenase (COX-1/COX-2) inhibiting property of 3,4-diarylfuranones. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 42(3). 593–601. 2 indexed citations
16.
Pal, Manojit, et al.. (2003). Conformationally restricted 3,4-diarylfuranones (2,3a,4,5-tetrahydronaphthofuranones) as selective cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(10). 1639–1643. 45 indexed citations
17.
Misra, Parimal, Chao Qi, Songtao Yu, et al.. (2002). Interaction of PIMT with Transcriptional Coactivators CBP, p300, and PBP Differential Role in Transcriptional Regulation. Journal of Biological Chemistry. 277(22). 20011–20019. 68 indexed citations
18.
Misra, Parimal, Edward D. Owuor, Wenge Li, et al.. (2002). Phosphorylation of Transcriptional Coactivator Peroxisome Proliferator-activated Receptor (PPAR)-binding Protein (PBP). Journal of Biological Chemistry. 277(50). 48745–48754. 60 indexed citations
19.
Bhatt, Kamlesh, et al.. (2000). Involvement of a natural transport system in the process of efflux-mediated drug resistance in Mycobacterium smegmatis. Molecular and General Genetics MGG. 262(6). 949–956. 40 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey A. Robl Breakdown of academic impact, for papers by Mitchell A. Avery Breakdown of academic impact, for papers by Antonella Del Corso Breakdown of academic impact, for papers by Toshimasa Itoh Breakdown of academic impact, for papers by Cecilia S. Koble Breakdown of academic impact, for papers by András Váradi Breakdown of academic impact, for papers by Dennis Dean Breakdown of academic impact, for papers by Richard Sulsky Breakdown of academic impact, for papers by Mark M. Yore Breakdown of academic impact, for papers by Junya Ito
Rankless by CCL
2026